Cephalon, Inc. (CEPH) – New Coverage
-
Goldman Sachs Resumes Cephalon (CEPH) at Neutral
-
Goldman Sachs Resumes Coverage on Valeant Pharmaceuticals (VRX) at Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CEPH Stock Lookup